Jakko van Ingen

Radboud University Nijmegen — Netherlands

Medicine · Health Sciences

69h-index18.6kcitations394works3.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Mycobacterium research and diagnosis(323), Tuberculosis Research and Epidemiology(262), Infectious Diseases and Mycology(128), Quinazolinone synthesis and applications(42), Infectious Diseases and Tuberculosis(29)

Publications388 total

Safety and tolerability of a standardized treatment regimen for Mycobacterium abscessus otomastoiditis
International Journal of Pediatric Otorhinolaryngology·2026Open Access
Treatment and outcomes in patients with non-TB mycobacterial pulmonary disease: a single-centre study
IJTLD OPEN·2026Open Access
Clinical Characteristics and Management of Non-Tuberculous Mycobacterial Skin and Soft Tissue Infections: A Retrospective Cohort Study
Open Forum Infectious Diseases·2025Open Access
Clinical standards for antimicrobial stewardship in TB care
IJTLD OPEN·2025· 1 citedOpen Access
Enhanced antimycobacterial efficacy of simulated inhaled clofazimine versus oral clofazimine in combination with azithromycin and ethambutol in a hollow-fiber system
Journal of Antimicrobial Chemotherapy·2025Open Access
Consensus on the management of refractory nontuberculous mycobacterial pulmonary disease
European Respiratory Journal·2025· 1 cited
A viable but nonculturable state of Mycobacterium avium in response to macrolide antibiotics: a recipe for relapses?
Journal of Medical Microbiology·2025Open Access
A systematic review of tetracyclines for nontuberculous mycobacteria: focus on rapidly growing mycobacteria
European Respiratory Review·2025· 1 citedOpen Access
65 Pseudomonas aeruginosa rapidly kills non-tuberculous mycobacteria in dual-species biofilms in vitro
Journal of Cystic Fibrosis·2025
Tigecycline dry powder inhalation to cure Mycobacterium abscessus lung disease: a dose finding study
2025
Phenotyping with single-dose isoniazid to identify slow acetylators in patients with drug-induced hepatotoxicity
2025
Pseudomonas aeruginosa rapidly kills non-tuberculous mycobacteria in dual-species biofilms in vitro
2025
Rifampicin leads to subtherapeutic azithromycin exposures in NTM disease treatment
2025
The spectrum of CFTR dysfunction in patients with nontuberculous mycobacterial pulmonary disease
Respiratory Investigation·2025Open Access
Survey on therapeutic drug monitoring practices for nontuberculous mycobacterial infections: an NTMnet/ESGMYC collaborative study
ERJ Open Research·2025Open Access
Can the BACES score predict clinical outcomes in a Dutch cohort with nontuberculous mycobacterial pulmonary disease?
ERJ Open Research·2025Open Access
Non-tuberculous mycobacterial disease in a high TB/HIV burden setting
IJTLD OPEN·2025· 1 citedOpen Access
Management of Nontuberculous Mycobacterial Pulmonary Disease Refractory to Guideline-Based Therapy: A Systematic Review
2025· 1 citedOpen Access
Medication adherence in patients with nontuberculous mycobacterial disease
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases·2025· 1 citedOpen Access
Preclinical Evidence for Phage Therapy to Treat Mycobacterial Infections: A Narrative Review
PHAGE·2025· 1 citedOpen Access
page 1 of 20Next →

Frequent Co-authors

Dick van Soolingen(18), Martin J. Boeree(16), Charles L. Daley(12), Kevin Winthrop(10), Dirk Wagner(10), Richard J. Wallace(9), Erik C. Böttger(9), David E. Griffith(9), Enrico Tortoli(8), Christoph Lange(8), Kenneth N. Olivier(8), Theodore K. Marras(7), Emmanuelle Cambau(7), Wouter Hoefsloot(6), P.N.R. Dekhuijzen(6), Rachel Thomson(6), Lorenzo Guglielmetti(6), Miguel Santín(6), Jason E. Stout(6), Shandra L. Knight(5)